so keep Update your ideas with the new addition of $IBO
Update your watch list with the new addition of $IBO Stocks veered from bearish to bullish day by day & leaving investors amazed in the Tsx_v market
UI is a life sciences industry on a mission to show the safety and efficacy of its ibogaine-based drug detox procedure in a planned Canadian Clinical Trial, with the goal of eventually licensing the protocol around the world.
The UI story will be distributed through numerous platforms and audiences by Blue Digital. The expected outcome is increased knowledge of UI's plans to conduct research into the use of ibogaine as part of a continuum of care for opioid addiction and other addictions.
Dr. Sola, a co-founder of Universal Ibogaine and a member of its Board of Directors, has...
Universal Ibogaine is working with Health Canada to undertake a planned clinical trial in Canada to demonstrate the safety and efficacy of the Ibogaine treatment protocol for opioid use disorder.
$IBOGF has established a remarkable market cap as compared to its fellow penny stocks in the market, currently the market cap is valued at $9.07 Million which has increased twice within a week.
At the Kelburn Clinic, UI is developing a cutting-edge holistic addiction treatment protocol that, when combined with the anticipated ibogaine detox programme, will transform the way we treat addiction and dramatically enhance the lives of individuals and families plagued by addiction.
"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." Alike Blue Digital Media’s expertise radar
Universal Ibogaine Inc. CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedelic medications, Germany has a reputation for...
With the current buyout price of $0.095, the company has around 6.5 million+ market cap, proliferating exponentially. Add the life science-based stock in your watch list and boost your portfolio.
$IBOGF is trading swiftly in the market and observing a plenty of investor activities, the shares are trading live on OTC at $0.095 with an amazing 178% profit on value per share.
Dr. Sola, a co-founder of Universal Ibogaine and a member of its Board of Directors, has effectively administered over 3,700 ibogaine treatments, more than any other doctor in the world, at an independent clinic in Cancun, Mexico, where he is a partner.
Blue Digital will be paid USD 27,000 for a three-month commitment beginning June 13, 2022. Additionally, Blue Digital will get 450,000 company's stock options to purchase common shares of the Company, with an exercise price of $0.10 per share, a three-year term, and one-third vesting at the conclusion of each month of service.
Universal Ibogaine Inc. is a life science company listed on OTC with the ticker symbol $IBOGF, currently sits at $0.0341 with the average market volume of 5k+
The company has filled out all the space of security data over the OTC market with a total of 190.7 million as the share outstanding, out of which 70.15 million has been issued and allowed for publicly-traded activities viewed as share float. $IBOGF currently lands on a 6.5 million market cap.
Boost your portfolio with $IBOGF, trading on the OTC platform.
Universal Ibogaine Inc. is a Canadian Life science company trading at TSX-V with the ticker symbol $IBO currently sits at $0.0450 with volume around $25K+. invest now for getting higher return
